Joint Formulary & PAD

Lamotrigine - Depression

You are here : Home > Formulary Search > Lamotrigine - Depression

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Guidelines
SPC
Restrictions / Comments :
 

Status 2

Blue
Formulations :
  • Dispersible tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Guidelines
SPC
Restrictions / Comments :
Important

Reserve for use in patients who are unable to swallow tablets.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Lamotrigine
Indication :
Depression
Group Name :
Keywords :
depressive episodes, depression prophylaxis
Brand Names Include :
Important Information :
  • Prophylaxis of depressive episodes in bipolar disorder.
  • Prophylaxis of recurrent depression (off-label use).

Initiation and stabilisation by the specialist mental health team for at least 1 month before any request for transfer of prescribing responsibility to primary care.

NOTE - brand prescribing is not required for mood stabilisation. Prescribe generically.

Risk of rash on treatment initiation or after a treatment break.

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Depression
Supporting Documents :
0
Traffic Light Entries :
2

Committee Recommendations (0)

  • No records returned.

Other Indications

Below are listed other indications that Lamotrigine is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Depression.